CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
* Total revenue for 2023 was RMB463.8 million, with commercial revenue of RMB 368.1 million * H...
CIEF 2021 kicks off, 6,000 plus projects exhibited online and offline ("Empower the Dual Circulation & Boost the New Development," 2021 CIEF opens)
GUANGZHOU, China, Dec. 11, 2021 /PRNewswire/ -- On December 10, the 2021 China Innovation and Entre...
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial
Not intended for US, Canada and UK-based media DARMSTADT, Germany, and NEW YORK, Nov. 8, 2019 /PRN...
C-SUITE SPEAKER LINE UP ANNOUNCED FOR 2022 WORLD EDITION OF BREAK THE CEILING TOUCH THE SKY SUMMIT
Top Executives from Mastercard, Coca-Cola, HP, PepsiCo, Kroger, Accenture, BIC, Fine Hygienic Holdi...
Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
The company will present the preclinical data of five novel drug candidates at AACR 2022 (onApril 8...
Brii Biosciences Announces Positive Data from a Randomized, Single-Blind Study of its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China
Data are consistent with the results of the global Phase 3 ACTIV-2 trial, demonstrating a favorable...
Yum China to Introduce the Revolutionary Beyond Burger® at Select KFC, Pizza Hut and Taco Bell Restaurants
SHANGHAI, June 1, 2020 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYS...
RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks
Enrollment completed in the U.S. Phase 2 study evaluating opaganib's safety and initial efficacy si...
European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
- BAVENCIO maintenance treatment significantly extended median overall survival versus standard of ...
BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for US-, Canada- and UK-based media - At the planned interim analysis, Phase III J...
Campaign Urges Governments at Next Year's UN Climate Conference to Back Compulsory Climate Education and Literacy
Urgent Action Needed to Equip All Youth with the Knowledge and Skills Needed to Join Green Economy ...
Social Capital Hedosophia Holdings Corp. Announces Date of Extraordinary General Meeting of Shareholders to Approve Business Combination with Virgin Galactic
Meeting Scheduled for October 23, 2019 NEW YORK, Oct. 10, 2019 /PRNewswire/—Social Capital Hedosoph...
CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma
Not intended for US, Canada and UK-based media * Opinion based on Phase III data showing combina...
The International Chamber of Commerce - Hong Kong Celebrates 25 Years of Services Elevating Hong Kong's International Reputation
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- The International Chamber of Commerce – Hong Kong (ICC-HK) ...
Global Times: China-Serbia ironclad friendship sets a role model in the new era: Chinese Ambassador to Serbia Li Ming
BEIJING, May 8, 2024 /PRNewswire/ -- China and Serbia have long been renowned for their ironclad fr...
New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019
Not intended for US, Canada and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 27, 2019 /P...
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2021
* 13 significant clinical milestones achieved year-to-date, including critical positive data read...
Global Times: China's progress between two Olympics impresses world
BEIJING, Feb. 5, 2022 /PRNewswire/ -- At 8 pm on Friday, Beijing officially became the world's firs...
FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma
DARMSTADT, Germany and NEW YORK, July 1, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) tod...
Merck and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for US-, Canada- and UK-based media - Breakthrough Therapy Designation and Submissio...